Similar articles

• Adverse-drug-reaction monitoring.

  Faich GA. Faich GA. N Engl J Med. 1986 Jun 12;314(24):1589-92. doi: 10.1056/NEJM198606123142427. N Engl J Med. 1986. PMID: 3713757 No abstract available.
• Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.

  Kessler DA. Kessler DA. JAMA. 1993 Jun 2;269(21):2765-8. doi: 10.1001/jama.269.21.2765. JAMA. 1993. PMID: 8492403 No abstract available.
• Adverse drug event reporting. Improving the low US reporting rates.

  Edlavitch SA. Edlavitch SA. Arch Intern Med. 1988 Jul;148(7):1499-503. Arch Intern Med. 1988. PMID: 3382293 No abstract available.
• Drug therapy of the aged: the problem of compliance and the roles of physicians and pharmacists.

  Gryfe CI, Gryfe BM. Gryfe CI, et al. J Am Geriatr Soc. 1984 Apr;32(4):301-7. doi: 10.1111/j.1532-5415.1984.tb02026.x. J Am Geriatr Soc. 1984. PMID: 6368654 Review. No abstract available.
• Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.

  Neely M, Jelliffe R. Neely M, et al. J Clin Pharmacol. 2010 Jul;50(7):842-7. doi: 10.1177/0091270009356572. Epub 2010 Feb 12. J Clin Pharmacol. 2010. PMID: 20154293 Review. No abstract available.